Quest Diagnostics earnings bolstered by March rebound, sending stock up 3%

Quest Diagnostics earnings bolstered by March rebound, sending stock up 3%
Quest Diagnostics closes acquisition of OhioHealth lab assets
Quest Diagnostics completes LifeLabs acquisition
Quest Diagnostics to acquire Canada’s LifeLabs for about $985 million, including debt
Quest Diagnostics to buy lab test provider LifeLabs for $985M
21.77BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US74834L1008
CUSIP
74834L100
Sector
Healthcare
Industry
Diagnostics & Research
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
21.58
PEG Ratio
1.52
Book Value
66.36
Dividend Share
3.26
Dividend Yield
1.66%
Earnings Share
9.04
Wall Street Target Price
223.13
EPS Estimate Current Year
10.76
EPS Estimate Next Year
11.65
EPS Estimate Current Quarter
2.3671
EPS Estimate Next Quarter
2.868
Most Recent Quarter
-
Revenue TTM
11,278,000,128
Gross Profit TTM
3,752,999,936
EBITDA
2,225,999,872
Profit Margin
9.08%
Return On Assets TTM
6.35%
Return On Equity TTM
14.54%
Revenue Per Share TTM
101.833
Qtly Revenue Growth YOY
9.20%
Diluted Eps TTM
9.04
Qtly Earnings Growth YOY
15.50%
Trailing PE
21.58
Forward PE
18
Price Sales TTM
1.9145
Price Book MRQ
2.955
Enterprise Value Revenue
2
Enterprise Value EBITDA
12
18.12
12.55%159.25
0.16%61.12
-1.80%617.40
-1.23%563.40
-0.88%114.15
-0.62%468.00
-0.52%299.30
-0.48%200.00
-0.41%178.82
-0.10%